Naseem Amin MD

Naseem Amin MD General Information

Biography

Dr. Naseem Amin served as Venture Partner at Advent Life Sciences. He joined Advent in 2014 bringing 24 years of trans-Atlantic industry experience in R and D, corporate development, business development, and marketing. He most recently served as Chief Scientific Officer at Smith and Nephew, where he oversaw corporate R&D, divisional manufacturing, QA/QC, and product development functions. Prior to Smith and Nephew, he led business development at both Biogen Idec and at Genzyme Therapeutics, for both of which companies, he initiated and executed a number of transformative acquisitions and transactions. He has also led the clinical development of five currently marketed therapeutic products. He started his career at Baxter Healthcare where he had executive roles in marketing, product development, and clinical research. In addition to his role at Advent, he currently works as a board member and advisor to several not-for-profit organizations. He is a qualified medical doctor, from the Royal Free & University College Medical School, London, and has an MBA from Kellogg Graduate School of Management. He is CEO of the Advent portfolio company GMPO.